Merck says cholesterol drug failed to show benefit
Drugmaker Merck & Co. said it will not seek U.S. approval for its cholesterol drug Tredaptive and is recommending doctors abroad stop prescribing it to new patients, based on failed study results.
Medications
Dec 20, 2012 |
not rated yet |
0
Germany's Merck suffers setback with cancer drug
German pharmaceutical company Merck KgaA says a late stage trial of a new lung cancer drug has failed to meet expectations.
Medications
Dec 19, 2012 |
not rated yet |
0
New Alzheimer's drug studies offer patients hope (Update)
For Alzheimer's patients and their families, desperate for an effective treatment for the epidemic disease, there's hope from new studies starting up and insights from recent ones that didn't quite pan out.
Alzheimer's disease & dementia
Dec 03, 2012 |
5 / 5 (1) |
0
Suvorexant drug may offer new approach to treating insomnia
A new drug may bring help for people with insomnia, according to a study published in the November 28, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.
Neuroscience
Nov 28, 2012 |
not rated yet |
0
|
FDA reviewing Merck's experimental insomnia drug
(AP)—Drugmaker Merck & Co. says the Food and Drug Administration is reviewing its experimental insomnia medication, suvorexant (SOO'vor-eks-ant).
Medications
Nov 08, 2012 |
not rated yet |
0
Fenofibrate / simvastatin benefit in dyslipidemia explored
(HealthDay)—Combination treatment with fenofibrate and simvastatin (FENO-S) significantly reduces postprandial (PP) triglyceride (TG) levels compared with simvastatin alone in all subjects, regardless of ...
Diabetes
Nov 01, 2012 |
4.5 / 5 (2) |
0
Cervical cancer vaccine shows promise
A vaccine against cervical cancer, being developed by Inovio Pharmaceuticals Inc. of Blue Bell, Pa., produced positive results in a small sample of 18 women.
Cancer
Oct 12, 2012 |
5 / 5 (3) |
0
Merck partnership accelerates needle-free vaccine delivery
A University of Queensland invention that will deliver vaccines without the need for needles has struck a significant partnership with US-based pharmaceutical giant Merck, announced today.
Medications
Oct 09, 2012 |
not rated yet |
0
Nonmedical school vaccination exemptions increasing
(HealthDay)—Nonmedical exemptions for school vaccination requirements have increased since 2005, particularly in states with easy exemption policies, according to a letter to the editor published in the ...
Health
Sep 20, 2012 |
not rated yet |
1
Merck KGaA suffers setback for cancer drug
German pharmaceuticals maker Merck KGaA said Tuesday it is withdrawing its application for its drug Erbitux to be used to treat patients with lung cancer.
Cancer
Sep 18, 2012 |
not rated yet |
0
Drug company Merck to cut 1 jobs in 10 in Germany
(AP)—German drug maker Merck KGaA is to eliminate one out of every 10 jobs in its home country.
Medications
Sep 04, 2012 |
not rated yet |
0
Bristol-Myers ends hepatitis C drug development
(AP)—Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure.
Medications
Aug 24, 2012 |
not rated yet |
0
Merck's 2Q net falls on charges, but sales rise
Merck & Co.'s second-quarter net income fell 11.4 percent as slightly higher sales were offset by acquisition and restructuring costs. However, the drugmaker beat Wall Street expectations, and Merck shares ...
Other
Jul 27, 2012 |
not rated yet |
0
Merck KGaA suffers setback on cancer drug
German pharmaceuticals maker Merck KGaA said Thursday that phase III clinical trials of its gastric cancer drug Erbitux had shown no benefits for patients.
Cancer
Jul 05, 2012 |
not rated yet |
0
Risk of sudden cardiac death up for black patients with HTN
(HealthDay) -- Black patients with hypertension face a significantly increased risk of sudden cardiac death (SCD) compared with nonblack patients, even after adjusting for multiple confounding variables, according ...
Cardiology
Apr 13, 2012 |
not rated yet |
0
